Addressing the Global Burden of Cardiovascular Disease in Women: JACC State-of-the-Art Review,Journal of the American College of Cardiology

当前位置： X-MOL 学术 › J. Am. Coll. Cardiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Addressing the Global Burden of Cardiovascular Disease in Women: JACC State-of-the-Art Review
Journal of the American College of Cardiology ( IF 21.7 ) Pub Date : 2024-06-17 , DOI: 10.1016/j.jacc.2024.04.028
Dominique Vervoort ₁ , Ruoting Wang ₂ , Guowei Li ₂ , Lynaea Filbey ₃ , Omosivie Maduka ₄ , LaPrincess C Brewer ₅ , Mamas A Mamas ₆ , Maria Cecilia Bahit ₇ , Sofia B Ahmed ₈ , Harriette G C Van Spall ₉

Affiliation

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Center for Clinical Epidemiology and Methodology (CCEM), Guangdong Second Provincial General Hospital, Guangzhou, China.
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Preventive and Social Medicine, University of Port Harcourt, Port Harcourt, Nigeria.
Department of Cardiovascular Medicine, Mayo Clinic College of Medicine, Minnesota Center for Health Equity and Community Engagement Research, Rochester, Minnesota, USA.
Keele Cardiac Research Group, Centre for Prognosis Research, Keele University, Stoke-on-Trent, United Kingdom.
INECO Neurociencias, Rosario, Santa Fe, Argentina.
Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Population Health Research Institute, Ontario, Canada; Baim Institute for Clinical Research, Boston, Massachusetts, USA.

Cardiovascular diseases (CVDs) are responsible for approximately 35% of all deaths in women. In 2019, the global age-standardized CVD prevalence and mortality of women were 6,403 per 100,000 and 204 per 100,000, respectively. Although the age- and population-adjusted prevalence has decreased globally, opposite trends are evident in regions of socioeconomic deprivation Cardiovascular health and outcomes are influenced by regional socioeconomic, environmental, and community factors, in addition to health care system and individual factors. Cardiovascular care in women is commonly plagued by delayed diagnoses, undertreatment, and knowledge gaps, particularly in women-specific or women-predominant conditions. In this paper, we describe the global epidemiology of CVD and highlight multilevel determinants of cardiometabolic health. We review knowledge and health care gaps that serve as barriers to improving CVD outcomes in women. Finally, we present national, community, health care system, and research strategies to comprehensively address cardiometabolic risk and improve outcomes in women.

中文翻译：

解决全球女性心血管疾病负担：JACC 最先进的审查

心血管疾病 (CVD) 约占女性所有死亡人数的 35%。 2019年，全球年龄标准化女性CVD患病率和死亡率分别为每10万人中6,403例和每10万人中204例。尽管全球范围内经年龄和人口调整后的患病率有所下降，但在社会经济贫困地区却存在明显相反的趋势。除了医疗保健系统和个人因素外，心血管健康和结果还受到区域社会经济、环境和社区因素的影响。女性心血管护理通常受到诊断延迟、治疗不足和知识差距的困扰，特别是在女性特有或女性占主导地位的疾病中。在本文中，我们描述了 CVD 的全球流行病学，并强调了心脏代谢健康的多层次决定因素。我们回顾了阻碍改善女性心血管疾病结局的知识和医疗保健差距。最后，我们提出了国家、社区、医疗保健系统和研究策略，以全面解决女性的心脏代谢风险并改善结果。

更新日期：2024-06-17

点击分享查看原文

点击收藏

阅读更多本刊新发论文本刊介绍/投稿指南